Granulosa cell ovarian cancer with synchronous multiple bone metastases: case report of extreme rarity

Tumori. 2021 Dec;107(6):NP54-NP58. doi: 10.1177/03008916211001438. Epub 2021 Mar 22.

Abstract

Background: Adult granulosa cell tumor (AGCT) of the ovary generally has a good prognosis. Recurrences tend to be late and confined to the abdominopelvis. Bone metastases are extremely rare. We report an extremely rare case of AGCT with synchronous multiple bone metastases and discuss diagnostic procedures and management.

Case description: A 35-year-old woman presented with abdominal bloating. On the day of surgery, acting on the complaint of right shoulder pain, an X-ray revealed a permeative lesion involving the neck of humerus, suggestive of a metastatic pathologic fracture. The patient underwent a full staging debulking surgery. Further imaging demonstrated multiple bone metastases. Histology confirmed an AGCT of the ovary. Diagnosis was established by a core bone biopsy from the left femur showing cells consistent with those seen with granulosa cell tumor. The patient received adjuvant chemotherapy with concurrent zoledronic acid as targeted therapy for her bone metastases. Endocrine systemic maintenance treatment was given. The patient rapidly deteriorated and died from her disease at 20 months from the initial diagnosis.

Conclusion: Unpredictable biological behavior and clinical manifestations raise a high degree of suspicion for accurate AGCT diagnosis. Management of bone metastases often warrants input from the multidisciplinary team, and treatment may involve chemotherapy, palliative radiotherapy, or orthopaedic interventions.

Keywords: Granulosa cell tumours; bone metastases; debulking surgery; multidisciplinary team; ovarian cancer.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Bone Neoplasms / drug therapy
  • Bone Neoplasms / secondary*
  • Chemotherapy, Adjuvant / methods
  • Female
  • Granulosa Cell Tumor / drug therapy
  • Granulosa Cell Tumor / pathology*
  • Humans
  • Neoplasms, Multiple Primary / drug therapy
  • Neoplasms, Multiple Primary / pathology*
  • Ovarian Neoplasms / drug therapy
  • Ovarian Neoplasms / pathology*
  • Prognosis
  • Rare Diseases / drug therapy
  • Rare Diseases / pathology*